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EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS
Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by
Epigenetic Regulation
YONG TANG, YAN LUO, ZONGLIANG JIANG, YINGHONG MA, CHIH-JEN LIN, CHUL KIM, MARK G. CARTER,
TOMOKAZU AMANO, JOONGHONG PARK, SHARON KISH, XIUCHUN (CINDY) TIAN
Center for Regenerative Biology, Department of Animal Science, University of Connecticut,
Storrs, Connecticut, USA
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ABSTRACT
Although leukemia inhibitory factor (LIF) maintains the
ground state pluripotency of mouse embryonic stem cells
and induced pluripotent stem cells (iPSCs) by activating
the Janus kinase/signal transducer and activator of transcription 3 (Jak/Stat3) pathway, the mechanism remained
unclear. Stat3 has only been shown to promote complete
reprogramming of epiblast and neural stem cells and partially reprogrammed cells (pre-iPSCs). We investigated if
and how Jak/Stat3 activation promotes reprogramming of
terminally differentiated mouse embryonic fibroblasts
(MEFs). We demonstrated that activated Stat3 not only
promotes but also is essential for the pluripotency establishment of MEFs during reprogramming. We further
demonstrated that during this process, inhibiting Jak/Stat3
activity blocks demethylation of Oct4 and Nanog regulatory elements in induced cells, which are marked by suppressed endogenous pluripotent gene expression. These are

correlated with the significant upregulation of DNA methyltransferase (Dnmt) 1 and histone deacetylases (HDACs)
expression as well as the increased expression of lysinespecific histone demethylase 2 and methyl CpG binding
protein 2. Inhibiting Jak/Stat3 also blocks the expression
of Dnmt3L, which is correlated with the failure of retroviral transgene silencing. Furthermore, Dnmt or HDAC
inhibitor but not overexpression of Nanog significantly rescues the reprogramming arrested by Jak/Stat3 inhibition
or LIF deprivation. Finally, we demonstrated that LIF/
Stat3 signal also represents the prerequisite for complete
reprogramming of pre-iPSCs. We conclude that Jak/Stat3
activity plays a fundamental role to promote pluripotency
establishment at the epigenetic level, by facilitating DNA
demethylation/de novo methylation, and open-chromatin
formation during late-stage reprogramming. STEM CELLS
2012;30:2645–2656
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INTRODUCTION
Induced pluripotent stem cells (iPSCs) are embryonic stem
cell (ESC)-like cells reprogrammed from differentiated cells
by overexpression of reprogramming factors including Oct4
(also known as Pou5f1), Klf4, Sox2, and c-Myc (OKSM) or
Oct4, Sox2, Nanog, and Lin28 [1–3]. The iPSC technology
holds great potential for regenerative medicine in producing
patient-specific pluripotent cells while bypassing embryo
manipulations. Methodologically, the induction of iPSCs has
evolved rapidly, from the initial viral transduction to recombinant proteins, modified mRNAs, or microRNAs [4–8]. However, the underlying mechanism for the molecular reprogramming remains ill-defined.
Activation of gene expression involves complicated epigenetic events such as DNA demethylation and histone methylation/acetylation, which render an open-chromatin structure for
the full access of transcriptional complexes [9–11]. Complete

reprogramming of somatic cells is marked by the full activation
of the Oct4 gene—the master regulator of pluripotency [12–14].
Accordingly, the Oct4 and Nanog enhancer/promoter elements
are hypermethylated in somatic cells and hypomethylated in
ESCs [2, 15, 16], whereas the histone hyperacetylation is closely
associated with Oct4 and Nanog regulatory regions in ESCs,
with hypoacetylation of these regions in somatic cells [2, 15].
Silencing of retroviral transgenes is a prerequisite for
pluripotency establishment in retroviral transgene-mediated
reprogramming, as overexpression of viral transgenes, especially Oct4, causes differentiation of pluripotent cells [13, 17,
18]. Retroviral silencing is achieved by de novo DNA methylation through DNA methyltransferases (Dnmts) 3a, 3b, and
Dnmt3L. Although Dnmt3L lacks a functional catalytic domain, it directly interacts with Dnmt3a/3b and significantly
enhances their activities [19–22]. Knocking-down of Dnmt3L
renders the ESCs incapable of silencing newly incorporated
retroviral DNA, demonstrating the essential role of Dnmt3L
expression in retroviral silencing [23].
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Activation of Janus kinase/signal transducer and activator
of transcription 3 (Jak/Stat3) signal pathway maintains mouse
ESC pluripotency [24]. Jak/Stat3 signal pathway is mainly
activated by leukemia inhibitory factor (LIF), which also activates the phosphatidylinositol 3-kinase (PI3K)/protein kinase
B (also known as Akt), and the extracellular-signal-regulated
kinases 1/2 (Erk1/2) pathways in ESCs [25–27]. LIF activates
these pathways through ligand-induced heterodimerization
between LIF receptor and the signal transducer protein gp130
[28, 29]. Artificially activated Stat3 sustains ESC self-renewal
in the absence of LIF [30]. Little is known about the downstream mechanism of Stat3 in pluripotency maintenance,
although it has been shown that LIF/Stat3 upregulates Klf4
and Myc expression in mouse ESCs [25, 31, 32], and Stat3
has been indicated to antagonize the differentiation signal of
Erk1/2 [33, 34].
The enhanced Stat3 activity has been shown to promote
complete reprogramming from mouse epiblast stem cells, neural stem cells, and OKSM-induced pre-iPSCs, which form
colonies but do not express key pluripotent genes such as
Oct4 and Nanog [35]. However, the underlying mechanism by
Stat3 during reprogramming remained unclear. In addition, it
was unknown whether LIF/Stat3 signaling can promote direct
reprogramming from terminally differentiated somatic cells.
Using mouse embryonic fibroblasts (MEFs) harboring the
green fluorescent protein (GFP) transgene driven by the Oct4
gene regulatory region (Oct-GFP-MEFs), we investigated
these questions and presented evidence to demonstrate that
the enhanced Stat3 activity improves direct MEF reprogramming, and that Jak/Stat3 activity is essential for reprogrammed cells to attain pluripotency. The underlying mechanism involves stimulation of DNA demethylation and de novo
methylation through regulating the expressions of Dnmts as
well as suppressing the expression of the major repressivechromatin relevant genes. We also show that inhibiting
Dnmt1 and histone deacetylases (HDACs) resumes reprogramming in the presence of Jak/Stat3 inactivation. We propose a model of Jak/Stat3 signaling to promote murine somatic cell reprogramming where Jak/Stat3 plays a primary
role for pluripotency accomplishment at late-stage reprogramming through epigenetic regulations.

RESULTS
Enhanced Stat3 Activation Promotes Direct MEF
Reprogramming
We used a constitutively active Stat3 (Stat3C) with A662C and
N664C substitutions in the SH2 domain, which prompts Stat3
dimerization and continued activation [36], and transfected
MEFs using Stat3C and the vector control to evaluate its function. As expected, 20 minutes of LIF addition stimulated rapid
phosphorylation of Akt, Stat3, and Erk1/2 in MEFs, iPSCs, and
ESCs as shown by Western blotting (Fig. 1A). In both the absence and presence of LIF, MEFs transfected with Stat3C
exhibited increased levels of phosphorylated Stat3 compared to
the vector control (Fig. 1A). This effect is reminiscent of
Stat3ER, a tamoxifen-inducible Stat3 construct [30]. Quantitative real time reverse transcriptase polymerase chain reaction
(qRT-PCR) analysis revealed that Stat3C expression in MEFs
significantly stimulated the expression of Socs3—the direct
Stat3 target, whose expression is further elevated by additional
LIF stimulation (Fig. 1B).
To evaluate whether enhanced Stat3 activation promotes
the reprogramming of terminally differentiated cells, we trans-

duced Oct4-GFP-MEFs with viral OKS or OKSM and further
transduced them with Stat3C or the control vector. Completely reprogrammed colonies are defined as those exhibiting
strong Oct4-GFP expression (GFPþ) 2 or 3 weeks after the
initial viral transduction (supporting information Fig. S1). In
OKS transduction, the expression of Stat3C increased the
number of GFPþ colonies by threefold compared to the vector control without LIF, an effect similar to the vector control
with LIF treatment (Fig. 1C). The maximum reprogramming
effect was achieved by the combination of LIF and Stat3C,
producing a 12-fold increase in the number of GFPþ colonies
over that of the control without LIF (Fig. 1C). The LIF/
Stat3C combination not only improved the total colony formation but also significantly improved the percentage of
GFPþ colonies (79%) compared to the LIF minus control
(43%) (Fig. 1D; supporting information Table S1), indicating
that Stat3 activation improves pluripotency achievement
among the induced colonies during late-stage reprogramming,
defined in this study as the establishment of pluripotency in
intermediate colonies. In OKSM-transduced MEFs, we also
observed a modest increase (1.6-folds) in the number of
GFPþ colonies by LIF/Stat3C combined treatments (Fig. 1E).
Importantly, similar to the OKS transduction, the percentage
of GFPþ colonies was significantly increased in LIF/Stat3Ctreated cells from 40% (control) to 79% (Fig. 1F). Improvement of both OKS and OKSM MEF reprogramming was also
observed using the mutant gp130 construct (gp130Y757F),
with a phenylalanine to tyrosine substitution at residual position
757, which blocks the activation of PI3K and Erk, and confers
constitutive Jak/Stat3 activation upon LIF stimulation [35, 37–
40] (Fig. 2A, 2B, dimethyl sulfoxide (DMSO) treatment).
Characterization of GFPþ colonies from OKS or OKSM
plus Stat3C-transduced MEFs demonstrated that these cells
were positive for alkaline phosphatase activity, readily grew
upon pick-up in 2i/LIF medium—the ground state selective
culture medium for ESCs [33, 41], and maintained bright GFP
expression and ESC-like colony morphology under repeated
passaging (Fig. 1G; supporting information Fig. S2). Testing
by qRT-PCR and immunostaining revealed that these cells
expressed endogenous ESC-specific genes/markers such as
Oct4, Nanog, Sox2, and SSEA-1 (Fig. 1H; supporting information Figs. S3–S6). The induced iPSCs also demonstrated pluripotency in vitro by embryoid body formation with the expression of three germ layer markers (supporting information Figs.
S7, S8) as well as the formation of beating cardiac cells upon
differentiation in serum-containing medium without LIF (supporting information online video 1). The retroviral Stat3C and
Oct4 expressions were also silenced in these iPSCs (supporting
information Fig. S9). Taken together, our results demonstrated
that the enhanced Stat3 activity promotes pluripotency establishment during late-stage OKS or OKSM reprogramming of
MEFs. In addition, Stat3 activity also promotes the total colony
formation in OKS induced MEF reprogramming.

Jak/Stat3 Activity Is Essential for Pluripotency
Establishment in Late-Stage MEF Reprogramming
It was indicated that the Stat3 activity represents a rate limiting
step in reprogramming, however, whether it is required for
complete reprogramming remained unknown [35]. In addition,
blocking Jak/Stat3 signaling was shown to improve the neural
progenitor cell generation for OKSM transduction of MEFs in
a neuronal medium [42]. To address whether Jak/Stat3 activity
is required for the complete reprogramming of somatic cells,
we reprogrammed Oct4-GFP-MEFs in the presence of LIF and
cultured them with either DMSO control or a low dosage
(1 lM) of the reversible Jak inhibitor I (Jaki) [25, 42], starting
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Figure 1. Enhanced Stat3 activation promotes MEFs reprogramming. (A): Western blots of total proteins extracted from B6/129-MEFs, R1ESCs, and B6/129 iPSCs previously generated in our lab using retroviral OKSM. The specific proteins probed were Akt, Stat3, Erk1/2 and their
phosphorylated forms. Tubulin was used as the loading control. (B): Relative levels of mRNA (mean 6 SD) for LIF receptor (LIFR), Akt, Stat3,
and Socs3 in B6/129 MEFs transfected with retroviral GFP control or Stat3C. ‘‘c’’ indicates the combined endogenous Stat3 and retroviral Stat3C
transgene expression. Values were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and relative to GFP control cells without
LIF stimulation; **, p ¼ .000, n ¼ 2). (C, D): The number (mean 6 SD) of GFPþ colonies (C) and the percentages of GFPþ colonies among
total ESC-like colonies (D) induced by Stat3C or vector control from Oct4-GFP-MEFs 3 weeks after reprogramming by OKS cultured with or
without LIF (*, p ¼ .0032; **, p ¼ .000; n ¼ 2). (E, F): The number (mean 6 SD) of GFPþ colonies (E) and the percentage (mean 6 SD) of
GFPþ colonies among total ESC-like colonies (F) at 3 weeks after retroviral OKSM plus vector or Stat3C transduction of Oct4-GFP-MEFs, cultured in medium with or without LIF (**, p ¼ .002; n ¼ 2). (G): Representative iPSC colonies at passage 5 induced by OKS plus Stat3C (OKSSC) or OKSM plus Stat3C (OKSM-SC) and cultured in 2i/LIF medium (scale bar ¼ 250 lm). (H): Relative levels of mRNA (mean 6 SD) for
the endogenous Oct4, Sox2, and Nanog in iPSC colonies at passage 6. The values were normalized with GAPDH and relative to R1-ESC (3F:
OKS; 4F: OKSM; SC: Stat3C. n ¼ 2). Abbreviations: ESC, embryonic stem cell; GFP, green fluorescent protein; iPSC, induced pluripotent stem
cell; LIF, leukemia inhibitory factor; LIFR, LIF receptor; MEF, mouse embryonic fibroblast; OKSM, Oct4, Klf4, Sox2, and c-Myc; Stat3, signal
transducer and activator of transcription 3.

at day 3 of viral transduction. Jaki treatment virtually blocked
any GFPþ colony formation in either OKS- or OKSM-induced
MEF reprogramming, regardless of the expression of
gp130Y757F (Fig. 2A–2C). However, the formation and the
www.StemCells.com

total number of colonies bearing the ESC-like morphology
induced by OKSM were not affected by Jaki treatment (Fig.
2C, 2D). In contrast, inhibition of PI3K/Akt activity with 10
lM LY294002 only partially decreased but did not block the
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Figure 2. Janus kinase/signal transducer and activator of transcription 3 (Jak/Stat3) activity is essential for complete mouse embryonic fibroblasts (MEFs) reprogramming. (A): The number of GFPþ colonies (mean 6 SD) induced by OKS plus gp130Y757F or control retroviral vector,
cultured in LIF and in the presence of either DMSO or 1 lM Jaki. The colonies were scored at 3 weeks after the initial OKS viral transduction
(**, p ¼ .000, n ¼ 2). (B): The number of GFPþ colonies (mean 6 SD) induced by retroviral OKSM plus gp130Y757F or control vector, cultured with LIF and in the presence of either DMSO or 1 lM Jaki. The colonies were scored at 2 weeks after the initial OKSM transduction
(**, p ¼ .009, n ¼ 2). (C): Representative embryonic stem cell (ESC)-like colonies induced from Oct4-GFP-MEFs and treated with either
DMSO or Jaki as described in (B) (scale bar ¼ 250 lm). (D): The number of total ESC-like colonies (mean 6 SD) induced by OKSM in LIF
containing reprogramming medium with DMSO or 1 lM Jaki at 2 weeks after viral transduction (n ¼ 2). (E): The number of GFPþ colonies
(mean 6 SD) induced by OKSM in LIF and either DMSO or 10 lM LY294002. The colonies were scored at 3 weeks after OKSM transduction
(n ¼ 2). (F): Number of GFPþ colonies (mean 6 SD) induced by OKSM transduction of Oct4-GFP-MEFs reprogrammed without feeder cells, cultured in medium with either DMSO, DMSO þ LIF, or 1 lM Jaki þ LIF 18 days after viral transduction (**, p ¼ .000, n ¼ 2). Abbreviations:
DMSO, dimethyl sulfoxide; GFP, green fluorescent protein; LIF, leukemia inhibitory factor; OKSM, Oct4, Klf4, Sox2, and c-Myc; jaki, Jak inhibitor.

formation of GFPþ colonies, a result unlikely due to the possible cytotoxicity from LY294002 at this dosage, as judged
by the normal morphology and growth characteristics of the
reprogrammed cells and colonies under continued treatment
(Fig. 2E and data not shown). These results indicate that Jak/
Stat3 activation not only promotes but also is required for the
pluripotency establishment during late-stage reprogramming.
If Jak/Stat3 inhibition blocks pluripotency establishment
during reprogramming, then eliminating LIF, the Jak/Stat3activating cytokine, should produce a similar effect. To verify
this, we reprogrammed MEFs by retroviral OKSM in the
absence of LIF and without feeder cells to minimize LIF in

the culture medium [43, 44]. These treatments resulted in a
drastic reduction in GFPþ colony formation which was nearly
identical to inhibiting Jak/Stat3 in the presence of LIF
(Fig. 2F). Taken together, these data demonstrated that the
LIF-dependent activation of the Jak/Stat3, but not the PI3K/
Akt activity, is essential for the induced colonies to acquire
pluripotency during late-stage MEF cell reprogramming.

Jak/Stat3 Activity Promotes Retroviral Silencing
and Regulates Dnmt Expression
To determine how Jak/Stat3 activity regulates the pluripotency establishment during reprogramming, we analyzed the
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mRNA transcripts 18 days after OKSM transduction of
MEFs, in the presence of either DMSO or Jaki. While the endogenous pluripotent genes including Oct4, Nanog, and Rex1
are significantly upregulated in reprogrammed cells treated
with DMSO control, the expression of these genes in Jakitreated cells, although upregulated from un-reprogrammed
MEFs, was at least 7-, 4-, or 70-fold less than those in the
DMSO control cells, respectively (Fig. 3A). These results
confirmed that Jak/Stat3 inhibition renders the cells to cease
reprogramming at an early-stage of the process. The endogenous Sox2 mRNA, however, was similarly upregulated in
both the DMSO control and Jaki-treated cells (Fig. 3A) compared to the MEF control.
Interestingly, we found that the expressions of all four
retroviral transgenes were much greater (3–6-fold) in Jakitreated cells than in the DMSO-treated controls (Fig. 3A).
This suggested an impeded de novo DNA methylation to
silence the retroviral transgenes [19]. We therefore examined
the expression of Dnmts in reprogrammed cells. Testing by
qRT-PCR revealed that the expression of de novo methyltransferase Dnmt3a was further upregulated, and the expression of Dnmts 3b and 3L was stimulated dramatically in
DMSO control reprogrammed cells, compared to the parental
MEFs (Fig. 3B), indicating increased de novo methylation
activities. However, Jak/Stat3 inhibition completely blocked
Dnmt3L expression during reprogramming (Fig. 3B). In addition, Jak/Stat3 inhibition resulted in significantly elevated
Dnmt1 expression compared to the DMSO control (Fig. 3B).
To minimize the heterogeneity of cells in the analysis, we isolated/expanded three typical colonies from each treatment at
3-week after viral transduction and analyzed their gene
expression at passage 2. A twofold elevation of Dnmt1 and a
complete loss of Dnmt3L expression were consistently
observed in Jaki-treated cells, compared to the DMSO controls (Fig. 3C). In addition, Jaki-treated colonies exhibited
lower levels of Dnmt3a/3b compared to the DMSO-treated
colonies, which showed elevated levels of de novo Dnmts
above the ESCs, indicating a further stimulation of de novo
methylation activity in these control cells (Fig. 3C). In accordance with these findings, qRT-PCR analysis revealed that
while the retroviral transgenes were basically silenced in colonies treated with DMSO control, they remained highly
expressed in Jaki-treated cells (Fig. 3D).
The lysine methyltransferase G9a has been shown to
recruit Dnmt3a to the endogenous retroviral DNA and is
required to establish the silencing of exogenous Moloney murine leukemia viral DNA in ESCs by de novo methylation
[45, 46]. We therefore evaluated the G9a expression in
reprogrammed cells and found that its expression was not
affected by Jak/Stat3 inhibition (supporting information Fig.
S10). Thus, our results demonstrated that Jak/Stat3 stimulates
the silencing of retroviral transgenes through activating the
expression of Dnmt3L, the essential role of which for retroviral silencing has been demonstrated previously [23].

Jak/Stat3 Activity Promotes DNA Demethylation of
Pluripotent Genes and Suppresses the Expression of
Repressive Chromatin Relevant Genes during
Reprogramming
As Dnmt1 is responsible for maintaining the existing DNA
methylation pattern during cell division [19, 47], and enhanced
Dnmt1 expression is directly associated with the accelerated
entry into the S-phase as well as cellular transformation [48–
50], it is therefore not surprising for us to see a greater Dnmt1
expression in the reprogrammed cells and ESCs, which undergo
much rapid cell division compared to MEFs (Fig. 3B, 3C). Howwww.StemCells.com
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ever, we also found that Jak/Stat3 inhibition leads to significantly elevated Dnmt1 expression in reprogrammed cells compared to the control cells (Fig. 3B, 3C). This is correlated with
the arrested reprogramming by Jaki treatment, with only low
levels of activated endogenous pluripotent genes including Oct4
and Nanog (Fig. 3A, 3D). We then investigated if Jak/Stat3 inhibition directly affects DNA methylation of these genes during
reprogramming. DNA pyrosequencing revealed that obvious
DNA demethylation happened to the proximal promoter and distal enhancer regions of Oct4 in DMSO-treated control cells,
compared to the parental MEFs at day 18 after retroviral transduction (Fig. 3E). However, in cells treated with Jaki, these
regions remained hypermethylated, similar to those in MEFs
(Fig. 3E). The DNA hypermethylation of the Oct4 and Nanog
enhancer/promoter regions in Jaki-treated cells was further verified by bisulfite DNA sequencing (Fig. 3F; supporting information Fig. S11). Thus Jak/Stat3 inhibition blocks the DNA demethylation of pluripotent genes during reprogramming.
Dnmt1 had been identified as a direct target for Stat3,
which can either activate or repress the expression of its targets
[51]. We evaluated the effect of activated Stat3 on Dnmt1
expression in MEF cells. Four days after retroviral Stat3C
transduction, the levels of Dnmt1 mRNA were significantly
reduced compared to the control MEFs (Fig. 4A). These results
indicate that the Stat3 activity directly inhibits Dnmt1 expression and therefore promotes a passive DNA demethylation in
reprogrammed cells which are undergoing rapid cell division.
By converting the 5-methylcytosine to the 5-hydroxymethylcytosine (5hmC) followed by the base excision repair pathway, tet methylcytosine dioxygenase (Tet) proteins were shown
to promote active DNA demethylation in mammalian cells [52,
53]. However, Tet1 also functions to suppress Polycomb-targeted differentiation genes in ESCs [54, 55]. Tet1/2 expression
level increased in induced iPSCs compared to the parental
MEFs [56]. We found that during the reprogramming, Tet1
expression increased moderately at day 18 of retroviral iPSC
induction, and that Jaki treatment partially inhibited the Tet1
increase in reprogrammed cells (supporting information Fig.
12). However, the small difference in Tet1 expression between
DMSO- and Jaki-treated cells at this reprogramming stage does
not correlate well with the completely blocked pluripotency
establishment by Jaki treatment at 2-week time point after
iPSC induction (Fig. 2B, 2C). Our finding thus does not support an active DNA demethylation by Tet1 to be responsible
for the complete reprogramming, which is consistent with the
recent studies showing that Tet1 deletion in ESCs and the subsequent reduction of cellular 5hmC did not affect the expressions of key pluripotent genes including Oct4, Nanog, and
Sox2, as well as ESC pluripotency [56–58]. Interestingly, activated Stat3 also suppressed Tet1 expression in MEFs (Fig.
4A). Thus, our data suggest an upregulation of Tet1 expression
by unidentified factor(s), which is positively regulated by Stat3
signaling in the context of late-reprogramming stage.
Chromatin modification by histone acetylation is closely
associated with DNA demethylation, and HDAC inhibitors significantly improve the induction efficiency of iPSCs [59, 60].
We therefore investigated the effect of Jak/Stat3 inhibition on
the expression of class I HDACs during reprogramming. Analysis by qRT-PCR revealed that HDACs 2, 3, and 8 expressions
were mildly but significantly elevated in day-18 OKSM-transduced cells treated with Jaki over those treated with DMSO in
the control group (Fig. 4B). This was further confirmed in the
isolated colonies described in the previous result section, with
at least two- to fourfold increase for their gene expression by
Jaki treatment (Fig. 4C). In addition to the increased expression
of HDACs, we also observed significant increases in the
expression of AOF1, MeCP2, and methyl-CpG binding protein

Figure 3. Janus kinase/signal transducer and activator of transcription 3 (Jak/Stat3) activity regulates DNA methylation during reprogramming.
(A): Relative levels of mRNA (mean 6 SD) in MEFs, R1-ESCs, and Oct4, Klf4, Sox2, and c-Myc (OKSM)-transduced MEFs 18 days after initial viral transduction. The cells were treated with either DMSO or 1 lM Jaki (*Oct4, *Sox2, *Klf4, *Myc: combined retroviral transgene and
endogenous gene expression. Others represent endogenous gene expression only. Values were normalized with glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and log10 transformed relative to those in R1-ESCs, n ¼ 3). (B): Relative levels of mRNA (mean 6 SD) for different
Dnmts in MEFs, R1-ESCs, and OKSM-transduced MEFs treated with Jaki or DMSO 18 days after transduction. Values were normalized with
GAPDH and relative to R1-ESCs (**, all p values <.01, n ¼ 3). (C): Relative levels of mRNA (mean 6 SD) for different Dnmts in colonies isolated from OKSM-induced MEF 3 weeks after viral transduction. The cells were treated with either Jaki or DMSO and cultured to passage 2
(4F: OKSM). Results were normalized with GAPDH and relative to R1-ESCs (**, all p values <.01, n ¼ 3). (D): Relative expression levels of
pluripotent transcription factors in colonies isolated 3 weeks after transduction by OKSM and treated with either Jaki or DMSO treatment. The
cells were cultured to passage 2 (4F: OKSM. *Oct4, *Sox2, *Klf4, and *Myc: combined retroviral and endogenous gene expression). The others
represent endogenous gene expression only. The average values of duplicate sample preparations were normalized by GAPDH, log10 transformed
and relative to R1-ESCs. (E): Upper panel: Schematic diagram of the Oct4 gene at the DE, PE, and PP regions. Arrow denotes transcription start
site (TSS). Red and green bars denote regions for pyrosequencing and bisulfite DNA sequencing, respectively. Lower panel: Representative illustrations of DNA pyrosequencing results at the Oct4 DE and PP region in OKSM-transduced MEFs treated with 1 lM Jaki or DMSO 18 days after OKSM transduction. MEFs and R1-ESCs served as the controls. The numbers under the x-axis indicate the distance of each CpG dinucleotide
from the TSS. (F): Bisulfite DNA sequencing analysis to part of the Oct4 PE and PP regions in MEFs treated with DMSO or Jaki 3 weeks after
OKSM transduction and isolated colonies cultured to passage 3. MEF and R1-ESCs served as the controls. Filled and open circles represent
methylated and unmethylated CpGs, respectively. The percentage of total methylated CpGs for each analyzed region was given on top of each
dataset. Abbreviations: DMSO, dimethyl sulfoxide; DE, distal enhancer; Dnmt, DNA methyltransferase; ESC, embryonic stem cell; MEF, mouse
embryonic fibroblasts; PE, proximal enhancer; PP, proximal promoter.
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together, our findings indicate that Jak/Stat3 activity suppresses
Dnmt1 and HDACs expression, as well as the expression of
other repressive chromatin regulators during reprogramming,
thus facilitating DNA demethylation and open-chromatin formation at pluripotent loci. These potentiate the complete activation of pluripotency related genes by allowing full access of
transcriptional machineries.

Dnmt or HDAC Inhibition but not Nanog
Overexpression Significantly Rescues
Reprogramming Arrested by Jak/Stat3 Inactivation

Figure 4. Janus kinase/signal transducer and activator of transcription 3 (Jak/Stat3) activity suppresses Dnmt1 and HDAC expressions
during reprogramming. (A): Relative expression levels of mRNA
(mean 6 SD) for Dnmt1 and Tet1 in B6/129 MEFs transduced with
retroviral GFP or Stat3C as described in Figure 2(B) for 4 days. Values were normalized with glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and relative to GFP control (**, p ¼ .001; *, p ¼ .014, n ¼
2). (B): Relative expression levels of mRNA (mean 6 SD) for different
HDACs in MEFs, R1-ESCs, and Oct4, Klf4, Sox2, and c-Myc
(OKSM)-transduced MEFs treated with Jaki or DMSO at 18 days after
the initial transduction. Values were normalized with GAPDH and relative to R1-ESCs (**, all p values <.01, n ¼ 3). (C): Relative levels of
mRNA (mean 6 SD) for different HDACs, AOF1/2, and MeCP1-p66/
MeCP2 in isolated colonies induced by OKSM and treated with Jaki or
DMSO at 3 weeks after viral transduction. The cells were analyzed at
passage 2 (4F: OKSM). Values were normalized with GAPDH and relative to R1-ESCs (**, all p values <.01, n ¼ 3). Abbreviations: Dnmt,
DNA methyltransferase; DMSO, dimethyl sulfoxide; ESC, embryonic
stem cell; GFP, green fluorescent protein; HDAC, histone deacetylase;
MEF, mouse embryonic fibroblast; SC, Stat3C.

1-p66 (MeCP1-p66, also known as GATAD2B) in Jaki-treated
colonies over DMSO controls (Fig. 4C). AOF1 promotes
H3K4 demethylation, and MeCP2/1-p66 directly binds to
methylated DNAs and recruits HDACs, which are associated
with chromatin condensation and gene silencing [61–63].
Downregulation of these mRNA transcripts by ESC-specific
microRNA mir-302 was found to play a significant role in
global DNA demethylation during reprogramming [64]. Taken
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We have found that Jak/Stat3 inhibition resulted in significantly lower Nanog activation than the DMSO control at day
18 of MEF reprogramming by OKSM (Fig. 3A). To test
whether the inadequate Nanog expression caused the incomplete Oct4 activation under Jak/Stat3 inhibition, MEFs were
transduced with retroviral OKSM plus Nanog (OKSMN) and
reprogrammed without feeder cells. Reprogramming without
LIF or with LIF plus Jaki both blocked the GFPþ colony formation regardless of Nanog overexpression (Fig. 5A; supporting information Fig. S13). Thus, insufficient Nanog expression does not appear to be the direct cause for the trapped
reprogramming, and Nanog overexpression does not rescue
the impeded MEF reprogramming resulting from LIF deprivation or Jak/Stat3 inhibition.
To test whether the elevated expression of Dnmt1 or
HDACs represents a significant cause for the reprogramming
arrested by Jak/Stat3 inhibition at late stage, we transduced
MEFs with OKSM and treated them with LIF plus Jaki starting at day 3 as described earlier. As Dnmt inhibition at early
reprogramming stage resulted in cell death [16], we started
adding the Dnmt inhibitor, 5-Aza-20 -deoxycytidine (AZA), or
the HDAC inhibitor, valproic acid (VPA) and trichostatin A
(TSA) to the culture medium at day 9 until day 15. Treatment
with AZA in the presence of Jak/Stat3 inhibition resulted in a
2.7-fold increase in the number of GFPþ colonies by day 15,
while treating the cells with VPA produced a milder (1.7fold) increase in GFPþ colonies, compared to the Jaki treatment control (Fig. 5B). Upon removing Jaki and all other
inhibitors and allowing the cells (including the control) to
continue reprogramming for three additional days in LIF containing medium, we could still observe a significant twofold
and 1.7-fold increase in GFPþ colonies from the AZA or
VPA treated cells, respectively, compared to the control (Fig.
5B). Although the combined treatment of AZA/VPA resulted
in significant cytotoxicity in our study (data not shown), it is
possible that a combined Dnmt1/HDACs inhibition with less
cytotoxic and more specific action (such as small interfering
RNA) may result in a complete rescue of the Jaki-arrested
reprogramming. These results indicated that inhibition of
Dnmt1 or HDACs at least partially and significantly rescues
the reprogramming arrested by Jak/Stat3 inhibition.
To address further whether elevated HDAC expression is
a significant cause for the trapped reprogramming by the loss
of Jak/Stat3 activity, we transduced MEFs with OKSM and
deprived them of residual LIF with the LIF-antibody starting
at day 3 after viral transduction [65]. The cells were then further treated with VPA or TSA starting at day 9 until day 15
of OKSM transduction. The VPA treatment resulted in a significant sixfold increase in the number of GFPþ colonies at
day 15 compared to the LIF-antibody only control (Fig. 5C).
After replacing LIF antibody and all the inhibitors with LIFcontaining medium (including the LIF-antibody control) for
an additional 6 days, the VPA-treated cells still showed a 3.6fold increase in GFPþ colonies over the controls (Fig. 5C).
Furthermore, the percentage of GFPþ cells in VPA treatment
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Figure 5. Dnmt or HDAC inhibition but not Nanog expression rescues impeded reprogramming by Jak/Stat3 inhibition, and Jak/Stat3 activity
is essential for OKM-pre-iPSC reprogramming. (A): Fluorescence activated cell sorting (FACS) of GFPþ cells 3 weeks after viral OKSM plus
Nanog (OKSMN) transduction of MEFs and reprogrammed without feeders. Cells were treated without LIF or with LIF plus DMSO or Jaki (the
percentages of GFPþ cells, GFPþ%, in total live cells were given in the representative figures; n ¼ 2). (B): The number of GFPþ colonies
(mean 6 SD) 15 and 18 days after OKSM transduction of MEFs cultured in LIF containing medium. Cells were treated with Jaki starting on day
3, and AZA (0.5 lM), VPA (1 mM), or TSA (20 nM) was added in medium from day 9 to day 15. All inhibitors were washed away, and cells
were cultured in LIF-containing medium from day 15–18, results represent means from three individual wells (**, p ¼ .000, *, p ¼ .024). (C):
The number of GFPþ colonies (mean 6 SD) 15 and 21 days after OKSM transduction of mouse embryonic fibroblasts (MEFs) cultured without
LIF and feeder cells. LIFAb was added starting at day 3, VPA (1 mM) or TSA (20 nM) was added the same as described in (B). The medium
was then switched to LIF-containing medium for days 15–21, results represent means from three individual wells (*, p ¼ .022; **, p ¼ .003).
(D): The number of GFPþ colonies (mean þ SD) from OKM#5 pre-iPSCs. The cells were transduced with Sox2, Sox2 plus Stat3C, or control
retroviral vector for 24 hours, and then cultured in knockout serum replacement (KSR)-ESC medium without LIF, and treated with either DMSO
or 1 lM Jaki. GFPþ colonies were scored at 10 days after viral transduction. (**, p ¼ .000, n ¼ 2). (E): The number of GFPþ colonies (mean
6 SD) from OKM#5 pre-iPSCs. The cells were transduced with Sox2, Sox2 plus Stat3C, or control retroviral vector and cultured in KSR-ESC
medium with LIF and treated with either DMSO or 10 lM LY294002. GFPþ colonies were scored 10 days after viral transduction (**, p ¼
.000, n ¼ 2). (F): The number of GFPþ colonies (mean 6 SD) from OKM#5 pre-iPSCs. Cells were treated with either DMSO control or 25 lM
RepSox for 24 hours and then cultured in KSR-medium with or without LIF. GFPþ colonies were scored at 10 days after chemical treatment
(**, p ¼ .000, n ¼ 2). (G): The proposed model of Jak/Stat3 in promoting pluripotency establishment in murine somatic cell reprogramming.
LIF signal activates Jak/Stat3, which suppresses Dnmt1, HDACs, AOF1, and MeCP1-p66/MeCP2 expressions, and stimulates Dnmt3L/3b expressions. Suppression of Dnmt1/HDACs/AOF1/MeCP1-p66/MeCP2 facilitates the DNA demethylation at the pluripotent loci and the establishment
of an open chromatin structure, enabling these genes for complete activation. Dnmt3L expression stimulates the de novo DNA methylation activities of Dnmt3a/3b, which silences retroviral transgenes and probably linage commitment genes, in addition to Polycomb-mediated gene suppression. Together these epigenetic modulations mediated by Jak/Stat3 signaling promote the pluripotency establishment during reprogramming.
Abbreviations: AZA, 5-Aza-20 -deoxycytidine; DMSO, dimethyl sulfoxide; Dnmt, DNA methyltransferase; GFP, green fluorescent protein; HDAC,
histone deacetylase; Jak/Stat3, Janus kinase/signal transducer and activator of transcription 3; LIF, leukemia inhibitory factor; LIFAb, LIF antibody; OKM, Oct4, Klf4, and c-Myc; TSA, trichostatin A; VPA, valproic acid.
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23 was almost identical to the positive control cells
by LIF (without LIF-antibody), which is 12-fold
than the LIF-antibody only control (supporting inforFig. S14).

Interestingly, we noticed that VPA treatment showed a
more prominent rescue to the reprogramming arrested by the
LIF-antibody than by Jaki treatment. One possible reason
could be a difference in Erk activity, which impairs ESC self-
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renewal and promotes differentiation [27, 39]. As LIF stimulation strongly phosphorylates Erk1/2 in MEFs and LIFstarved ESCs/iPSCs as shown in our study (Fig. 1A) and previous research [25, 27], in Jaki treatment the Erk1/2 were
strongly activated in the presence of LIF. However, under
LIF-antibody conditions the VPA treatment could exert a
more significant rescue to the arrested reprogramming, due to
attenuated Erk differentiation signal without LIF cytokine,
under our reprogramming condition.
Therefore, temporary inhibition of Dnmt or HDAC during
the late-reprogramming stage can significantly revert the
arrested reprogramming in the presence of either Jak/Stat3 inhibition or LIF deprivation. Taken together, our results indicated that elevated expressions of Dnmt1 and HDACs but not
low levels of Nanog expression significantly contribute to
reprogramming arrested by Jak/Stat3 inhibition.

LIF/Stat3 Signaling Is Essential for Sox2 Overexpression or TGFb Inhibition-Induced Pre-iPSC
Reprogramming
The retroviral OKM-induced pre-iPSCs (OKM-pre-iPSCs) can
be completely reprogrammed to pluripotency by overexpressing Sox2 or Nanog [66]. Because we had determined that Jak/
Stat3 activation is essential for the late-stage reprogramming
of MEFs, we asked whether it is also required for the complete reprogramming of OKM-pre-iPSCs. Nine out of 12
GFP OKM-pre-iPSC cell lines responded to the retroviral
Sox2 induction, but only two responded to the retroviral
Nanog induction by expressing Oct4-GFP (supporting information Fig. S15). We chose OKM-pre-iPSC#5 and #18
(OKM#5 or #18) to study the role of Jak/Stat3 in Sox2-mediated complete reprogramming further. In the absence of LIF,
Stat3C expression significantly improved the Sox2-induced
complete reprogramming of both OKM#5 and #18, whereas
Jaki treatment blocked the GFPþ colony formation (Fig. 5D;
supporting information Fig. S16). Similar to MEF reprogramming, inhibition of PI3K/Akt activity by LY294002 only partially reduced but did not block the Sox2-induced reprogramming of either pre-iPSC cell line (Fig. 5E; supporting
information Fig. S17). These results demonstrated that Jak/
Stat3 activation is required for Sox2-induced complete reprogramming of OKM-pre-iPSCs.
The transforming growth factor beta (TGFb) receptor kinase inhibitor RepSox promotes complete reprogramming of
OKM-pre-iPSCs by stimulating endogenous Nanog expression
[66]. We asked whether the reprogramming by TGFb pathway
inhibition also depends on LIF signaling. In the presence of
LIF, treatment by RepSox greatly stimulated the reprogramming of OKM#5 pre-iPSCs (Fig. 5F). However, the reprogramming effect was completely diminished in the absence of
LIF (Fig. 5F; supporting information Fig. S18). Thus, the
complete reprogramming of OKM-pre-iPSCs promoted by inhibiting the TGF-b receptor also depends on LIF signaling.

DISCUSSION
We demonstrated here that elevated Stat3 activity significantly
enhances the pluripotency establishment of MEFs induced by
either OKS or OKSM. Enhanced Stat3 activation also
improves the total colony formation in OKS reprogramming.
The gene c-Myc is a direct target of Stat3 in ESCs. Constitutively activated c-Myc expression in ESCs maintains ESC
pluripotency in the absence of LIF [32, 67]. Addition of
c-Myc improves OKS reprogramming by promoting cell proliferation thus accelerating the reprogramming process [68].
www.StemCells.com
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This could explain why the enhanced Stat3 activation
increased the total colony formation in OKS but not in
OKSM transduction. Although we did not detect an upregulation of c-Myc in MEFs transfected with Stat3C (data not
shown), it is possible that the enhanced Stat3 activation
stimulated c-Myc expression in partially dedifferentiated cells
during the reprogramming, which further promoted cell proliferation and colony formation. However, in OKSM reprogramming, this effect of Stat3 would be rendered insignificant by
the overexpression of retroviral c-Myc.
Here, we demonstrated the essential role of Jak/Stat3 in
acquiring pluripotency during late-stage MEF reprogramming.
The constitutive retroviral transgene expression in the absence
of Jak/Stat3 activity may partially contribute to the incomplete reprogramming. Silencing of retroviral transgenes is a
prerequisite for pluripotency establishment in retroviral mediated reprogramming, as overexpression of pluripotent genes,
especially Oct4, leads to differentiation of ESCs [13, 17, 18].
It was demonstrated that Dnmt3L is the essential component
for retroviral silencing in ESCs by stimulating Dnmt3a/3b
activities, and retroviral expressing/silencing has been the tool
to study de novo methylation in pluripotent cells [19, 23].
Dnmt3a, 3b, and 3L are mainly expressed in ESCs and embryonic stages and are responsible for the proper establishment of imprinting during gametogenesis [69–72]. Mice lacking Dnmt3L exhibit imprinting defect [71, 72].
We discovered that Jak/Stat3 inhibition completely blocks
Dnmt3L expression and thus abrogates the stimulation of de
novo methylation activity specific for retroviral silencing during reprogramming. In addition to de novo methylation,
Dnmt3L is also required to maintain the DNA methylation
patterns in ESCs [23]. Our finding that Jak/Stat3 activity stimulates Dnmt3L expression therefore sheds new light on the
role played by LIF signaling for both pluripotency attainment
and maintenance.
We demonstrated that inhibition of Jak/Stat3 blocks DNA
demethylation of Oct4 and Nanog regulatory regions during
reprogramming, which is marked by significantly suppressed
endogenous pluripotent gene expression. Extensive epigenetic
change happens during the reprogramming process [16, 73–
75]. The promoter regions of pluripotent genes including
Oct4, Nanog, and Rex1 are hypermethylated in MEFs and
pre-iPSCs [2, 16] and hypomethylated in iPSCs and ESCs [1,
3, 13, 76, 77]. The efficiency for complete reprogramming of
somatic cells and pre-iPSCs by OKSM can be improved several-fold by inhibiting Dnmt1 with AZA or Dnmt1 specific
short hairpin RNAs [16, 59, 78]. In mouse placenta and trophoblast stem cells, where the Oct4 promoter region is hypermethylated, depletion or inhibition of Dnmt1 resulted in hypomethylation of the Oct4 promoter region and ectopic Oct4
expression [15]. These previous studies had established a
strong connection between Oct4 gene activation and DNA
demethylation promoted by suppression of Dnmt1 activity in
the context of specific developmental stages.
Histone acetylation is closely associated with DNA demethylation in the Oct4 promoter region in ESCs [2, 15], and
the HDAC inhibitor sodium butyrate was shown to improve
Oct4 promoter demethylation during OKSM reprogramming
of fibroblasts [60]. Inhibition of HDAC activity promotes the
ubiquitin-dependent proteasomal degradation of Dnmt1 [79,
80], further suggesting a synergistic promotion of DNA demethylation by suppression of both Dnmt1 and HDAC activities.
Although a passive model of genomic DNA demethylation as
a result of inhibited methylation maintenance has been proposed for reprogramming [81, 82], the actual mechanism that
the cells may control this process under extracellular cues has
remained unclear.
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We found that during reprogramming, the hypermethylation of Oct4 and Nanog enhancer/promoter regions as the
result of Jak/Stat3 inhibition is tightly correlated with the significantly elevated Dnmt1 and HDAC 2, 3, 8 expressions,
compared to the control reprogrammed cells. Accordingly, we
demonstrated that inhibiting Dnmt or HDAC activity by AZA
or VPA partially but significantly rescues the reprogramming
arrested by Jak/Stat3 inhibition or LIF deprivation. Our data
thus strongly argue that Jak/Stat3 signaling plays a critical
function in facilitating the demethylation of endogenous pluripotent genes and in promoting the formation of open-chromatin structure by suppressing the expression of Dnmt1 and
HDACs during reprogramming. In addition, we also found
that loss of Jak/Stat3 activity leads to the significant increase
of AOF1, MeCP1-p66, and MeCP2 expression. Downregulation of AOF1/2 and MeCP1-p66/MeCP2 mRNAs and the subsequent destabilization and degradation of Dnmt1 protein
have been indicated to be the mechanism of mir-302 expression mediated global DNA demethylation, which triggers the
activation of pluripotent genes [64, 83, 84]. Together, our
findings supported the central role of Jak/Stat3 activity in the
key epigenetic regulation events during reprogramming,
which prepares and potentiates the pluripotent genes for complete activation by transcriptional machineries.
Repressive-chromatin represents a major mechanical barrier to transcription factor induced reprogramming [85]. Oct4,
Sox2, and Nanog function as the core pluripotent gene circuitry in ESCs [86, 87]. The Oct4 gene enhancer/promoter
region contains binding sites for Oct4, Sox2, and Nanog proteins to activate its own transcription [87, 88].
We found that overexpression of Nanog together with the
transcription factor OKSM does not overcome the LIF deprivation or Jak/Stat3 inhibition for complete MEF reprogramming, which is marked by activation of endogenous Oct4
expression. In addition, both Sox2 expression and TGFb
signal inhibition failed to induce pluripotency in OKM-preiPSCs without Jak/Stat3 activation or LIF signaling. Therefore, the Jak/Stat3 activation represents a prerequisite for pluripotency establishment during the reprogramming of both terminally differentiated and partially reprogrammed cells.
The evidence we presented here thus support a model
(Fig. 5G) where Jak/Stat3 activation orchestrates the major
epigenetic events during reprogramming, to establish the
open-chromatin structure in pluripotent loci for the full access
of transcription factor complexes, thus allowing complete
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